Connor, Clark & Lunn Investment Management (CC&L)
ARNA

Connor, Clark & Lunn Investment Management (CC&L)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,579
Closed -$240K – 1294
2021
Q4 		$240K Sell
2,579
-13,781
-84% -$908K ﹤0.01% 936
2021
Q3 		$974K Buy
+16,360
New +$966K 0.01% 653
2019
Q4 		– Sell
-15,875
Closed -$727K – 1143
2019
Q3 		$727K Buy
15,875
+5,025
+46% +$282K 0.01% 603
2019
Q2 		$636K Buy
+10,850
New +$561K ﹤0.01% 673
2017
Q3 		– Sell
-14,691
Closed -$248K – 954
2017
Q2 		$248K Buy
14,691
+1,951
+15% +$26.8K ﹤0.01% 708
2017
Q1 		$186K Buy
12,740
+110
+0.9% +$1.63K ﹤0.01% 809
2016
Q4 		$179K Sell
12,630
-1,550
-11% -$24K ﹤0.01% 801
2016
Q3 		$248K Sell
14,180
-1,080
-7% -$17.9K ﹤0.01% 706
2016
Q2 		$261K Hold
15,260
– – ﹤0.01% 702
2016
Q1 		$301K Sell
15,260
-4,500
-23% -$72.1K ﹤0.01% 651
2015
Q4 		$375K Buy
19,760
+3,360
+20% +$68.5K ﹤0.01% 596
2015
Q3 		$313K Buy
+16,400
New +$557K ﹤0.01% 590

Connor, Clark & Lunn Investment Management (CC&L)'s ARNA Position: Q1 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,579 shares — an estimated $240K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ARNA in Q3 2015 and held it in 12 quarters. The position peaked at $974K in Q3 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 2,579 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $240K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Arena Pharmaceuticals Inc in Q3 2015 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Arena Pharmaceuticals Inc position peaked at $974K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.